Delivery Order SPE2DB24D1205-SPE2DB25FCWWQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Ebiglasss 250 mg/2 ml pen medication in 2 ml quantities. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $4,962.79 and is scheduled for completion by September 9, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion global...
- The Defense Logistics Agency awarded a $2,747.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ebyglss 250 mg/2 mL pens (2 mL quantity) with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed price delivery order valued at $6,636.12 by the Defense Logistics Agency (DLA) on May 30, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens with a completion date of June 2, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries...
- The Defense Logistics Agency awarded a $1,373.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ebylass 250 mg/2 ml pen injections. This non-set-aside competitive award is set for completion by September 16, 2025, with performance to take place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,747.38 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ebglyss 250 mg/2 ml pen (2 ml). This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitively awarded, non-set-aside contract with place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this award...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $8,408.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a $26.7K delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with an ultimate completion date of September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a pharmaceutical supplier to the federal government, leveraging...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies valued at $1,503.56 on August 27, 2025. The order encompasses Zymfentra 120 mg/ml pens in a 2-pack quantity, with an ultimate completion date of September 18, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is structured as a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,267.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on September 3, 2025, with completion by September 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWWQDelivery Order
The Defense Logistics Agency awarded a $3,785.17 delivery order to AmerisourceBergen Drug Corp on May 16, 2025, for the supply of Ebiglasss 250 mg/2 ml pens with a completion date of May 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That prime contract vehicle supports comprehensive pharmaceutical and medical supply requirements for Defense Health Agency and other federal healthcare systems globally. AmerisourceBergen's federal contracting history demonstrates consistent capability in delivering a broad portfolio of medications and medical supplies through competitive awards, positioning the company as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 5/16/25 |